On average, they anticipate verve therapeutics' stock price to reach $71.20 in the next year. Buy or sell verve therapeutics stock? 424b4 The stock has a consensus analyst rating of buy. a buy rating indicates that analysts believe verv will outperform the market and that investors should add to their positions of verve therapeutics. Verve therapeutics stock prediction . Verve therapeutics inc stock price forecast for further price development up to 6.55% (time horizon: Verve therapeutics inc () stock market info recommendations: The company traded as low as $30.89 and last traded at $31.41. The stock's lowest day price was 33.15. The biotech stock, which was as low as $41.52 a share on monday, climbed as high as $48.39 by thursday. Verve therapeutics currently has 2 hold ratings and 3 buy ratings from wall street analysts. The average price target for verv set by the institutional analysts is $73.78 where high estimate is $88.20, median $76.5 and low $58...